Divi's Laboratories rises on reporting 92% rise in Q3 consolidated net profit

11 Feb 2022 Evaluate

Divi's Laboratories is currently trading at Rs. 4334.10, up by 20.70 points or 0.48% from its previous closing of Rs. 4313.40 on the BSE.

The scrip opened at Rs. 4300.55 and has touched a high and low of Rs. 4475.00 and Rs. 4240.60 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 5,425.00 on 18-Oct-2021 and a 52 week low of Rs. 3,154.50 on 19-March-2021.

Last one week high and low of the scrip stood at Rs. 4475.00 and Rs. 4164.95 respectively. The current market cap of the company is Rs. 1,15,056.74 crore.

Divi's Laboratories has reported a rise of 96.69% in its net profit at Rs 907.22 crore for the quarter ended December 31, 2021 as compared to Rs 461.24 crore for the same quarter in the previous year. Total income of the company increased by 48.16% at Rs 2,483.39 crore for Q3FY22 as compared Rs 1,676.16 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 91.71% in its net profit at Rs 902.24 crore for the quarter ended December 31, 2021 as compared to Rs 470.62 crore for the same quarter in the previous year. Total income of the company increased by 45.86% at Rs 2,509.86 crore for Q3FY22 as compared Rs 1,720.76 crore for the corresponding quarter previous year.

 

Divis Lab Share Price

5817.40 -45.60 (-0.78%)
09-Jan-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.00
Dr. Reddys Lab 1373.60
Cipla 1491.70
Lupin 2250.40
Zydus Lifesciences 1008.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.